FB102 Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
Celiac Disease
Forte Biosciences, Inc.100 enrolled1 locationNCT06982963
Recruiting
Phase 1
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Vitiligo
Forte Biosciences, Inc.64 enrolled6 locationsNCT06905873
Recruiting
Phase 1
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Alopecia Areata
Forte Biosciences, Inc.32 enrolled6 locationsNCT07205159